Latest | F'cast | |
---|---|---|
Div Yield | 0.0% | 0.0% |
Div Cover | n/a | n/a |
Op Mrgn | -1060.3% | n/a |
ROCE | n/a |
Latest | F'cast | |
---|---|---|
P/E | n/a | n/a |
PEG | n/a | n/a |
Pr/Revenue | 17.8 | n/a |
Pr/Book | 1.7 |
Latest | F'cast | |
---|---|---|
Revenue | 810.9% | n/a |
PBT | n/a | n/a |
EPS | n/a | n/a |
DPS | n/a | n/a |
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
30-Jun-20 | 1.06 | (20.38) | (54.48)p | n/a | n/a | n/a | n/a | 0.0% |
30-Jun-21 | 0.69 | (1.85) | (1.19)p | n/a | n/a | n/a | n/a | 0.0% |
30-Jun-22 | 0.05 | (5.63) | 5.50p | 3.2 | n/a | n/a | n/a | 0.0% |
30-Jun-23 | 0.06 | (5.98) | (5.50)p | n/a | n/a | n/a | n/a | 0.0% |
30-Jun-24 | 0.50 | (7.75) | (4.70)p | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
Block Listing Returns | 30-May-2025 | 07:00 | RNS |
CE-certification | 30-May-2025 | 07:00 | RNS |
CYP2C19-ID Kit used to support expansion | 13-May-2025 | 07:00 | RNS |
Genedrive secures CE certification for CYP2C19 I... | 30-May-2025 | ShareCast |
Genedrive upbeat on publication of clinical perf... | 27-Dec-2024 | ShareCast |
Genedrive full-year revenue rises | 29-Nov-2024 | ShareCast |
No deals were found in the last 28 days.
Currency | UK Pounds |
Share Price | 1.48p |
Change Today | 0.050p |
% Change | 3.51 % |
52 Week High | 4.53 |
52 Week Low | 1.32 |
Volume | 3,174,635 |
Shares Issued | 624.90m |
Market Cap | £9.22m |
RiskGrade | 747 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
No dividends found |
Time | Volume / Share Price |
12:13 | 66 @ 1.51p |
12:12 | 200,000 @ 1.43p |
12:03 | 65 @ 1.53p |
11:58 | 105,928 @ 1.43p |
11:16 | 65 @ 1.53p |
You are here: research